Abstract

Natural products are an unsurpassed source of lead structures for drug discovery. However, these molecules, many of which fall into the beyond-rule-of-5 chemical space, are often difficult to optimize by chemical means because of their complex structures. Biosynthetic engineering of the producing host organism offers an important tool for the modification of complex natural products, leading to analogues which are unattainable by chemical semisynthesis. This review describes the current role of natural products in lead generation and the principles behind biosynthetic medicinal chemistry. It then goes on to describe five distinct drugs – salinosporamide, geldanamycin, FK506, rapamycin and epothilone – to exemplify how biosynthetic engineering approaches have contributed to the advancement of natural product clinical candidates.

Keywords

SemisynthesisNatural productChemical spaceDrug discoveryGeldanamycinChemistryNatural (archaeology)Biochemical engineeringChemical biologyCombinatorial chemistryComputational biologyBiologyStereochemistryBiochemistryEngineeringHsp90

Affiliated Institutions

Related Publications

Publication Info

Year
2012
Type
article
Volume
3
Issue
8
Pages
854-854
Citations
45
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

45
OpenAlex
0
Influential
41
CrossRef

Cite This

Frank E. Koehn (2012). Biosynthetic medicinal chemistry of natural product drugs. MedChemComm , 3 (8) , 854-854. https://doi.org/10.1039/c2md00316c

Identifiers

DOI
10.1039/c2md00316c

Data Quality

Data completeness: 77%